Salix Pharmaceuticals, Ltd. (SLXP) announced the pricing of a public offering of 5.5 million shares of its common stock. The offering is expected to close on or about November 23, 2009. In addition, Salix has granted the underwriter a 30-day option to purchase up to an additional 825 thousand shares to cover over-allotments, if any.
Salix intends to use the net proceeds from the offering for business development activities and other general corporate purposes.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.